Designing of a novel dextransucrase efficient in synthesizing oligosaccharides

Analysis of the Effect of N555 Mutations on the Product Specificity of Dextransucrase Using Caffeic Acid Phenethyl Ester as an Acceptor Substrate

Bioglycosylation is an efficient strategy to improve biological activities and physicochemical properties of natural compounds to develop structural modifications of drugs. In this study, an N555 residue was identified as a candidate for site-directed mutagenesis through sequence alignment with GTF180ΔN. Caffeic acid phenethyl ester (CAPE) was used as an acceptor substrate. Two generated mutants, N555Q and N555E, demonstrated significant specificity of distribution of products. Under identical conditions, the conversion rates of diglycoside products (CAPE-2G) generated by the N555E (80.8%) and N555Q (84.5%) mutants were 3.30- and 3.46-fold higher than those generated by the original enzyme (24.4%). The structural simulation results demonstrated that a new hydrogen bond was formed between the N555 residue and CAPE, and the N555 residue was closely related to substrate elongation. These results provide a reference for subsequent studies. Suitable mutants for transfer of diglycosides have important application potential in the food and pharmaceutical industries.

Different strategies to co-immobilize dextransucrase and dextranase onto agarose based supports: Operational stability study

Co-immobilization is a groundbreaking technique for enzymatic catalysis, sometimes strategic, as for dextransucrase and dextranase. In this approach, dextranase hydrolytic action removes the dextran layer that covers dextransucrase reactive groups, improving the immobilization. Another advantage is the synergic effect of the two enzymes towards prebiotic oligosaccharides production. Thus, both enzymes were co-immobilized onto the heterobifunctional support Amino-Epoxy-Glyoxyl-Agarose (AMEG) and the ion exchanger support monoaminoethyl-N-ethyl-agarose (Manae) at pH 5.2 and 10, followed or not by glutaraldehyde treatment. This work is the first attempt to immobilize dextransucrase under alkaline conditions. The immobilized dextransucrase on AMEG support at pH 10 (12.78 ± 0.70 U/g) presents a similar activity of the biocatalyst produced at pH 5.2 (14.95 ± 0.82 U/g). The activity of dextranase immobilized onto Manae was 5-fold higher than the obtained onto AMEG support. However, the operational stability test showed that the biocatalyst produced on AMEG at pH 5.2 kept >60% of both enzyme activities for five batches. The glutaraldehyde treatment was not worthwhile to improve the operational stability of this biocatalyst.

Engineering Leuconostoc mesenteroides dextransucrase by inserting disulfide bridges for enhanced thermotolerance

The disulfide bridge is a very important part of the peptide chain and plays an important role in stabilizing the protein structure and maintaining its active function. One hundred and fourteen potential disulfide bridges were determined by Disulfide by Design™, and 4 disulfide bridges were constructed for the purpose of obtaining new enzyme species with high thermotolerance. High thermotolerance is achieved by increasing the number of hydrogen bonds between amino acids. The optimum temperatures of mutant L838C-V887C and A948C-A1013C were improved by 10 °C compared to that of the original enzyme, which was beneficial to reduce the viscosity of the reaction system. Some of the mutations resulted in the alteration of catalytic specificity, and the products D739C-F932C and A948C-A1013C catalyzed synthesis of dextran containing a new α(1-4) glycosidic linkage and α(1-2) glycosidic linkage. This study may provide information valuable for increasing the reaction temperature of recombinant dextransucrase. The molecular docking study presents a plausible explanation for reaction specificity alteration and optimum temperature improvement for the mutants.